Sharp Shalini has filed 19 insider transactions across 4 companies since May 2023.
Most recent transaction: a grant/award of 16623 shares of Septerna, Inc. ($SEPN) on June 17, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 17, 2025 | Septerna, Inc. | $SEPN | Sharp Shalini | Not found | A | Stock Option (Right to Buy) | 16623 | $0.00 | 16,623.0000 | 9,891,126 | 9999.99% | 0.17% |
| June 13, 2025 | Organon & Co. | $OGN | Sharp Shalini | Director | A | Phantom Stock | 23904 | $10.04 | 63,054.1480 | 259,152,000 | 61.06% | 0.01% |
| May 21, 2025 | BeOne Medicines Ltd. | $ONC | Sharp Shalini | Director | A | Share Option (Right to Buy) | 22750 | $0.00 | 22,750.0000 | 1,368,746,793 | 9999.99% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | M | Restricted Stock Unit | 1435 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 21, 2025 | BeOne Medicines Ltd. | $ONC | Sharp Shalini | Director | A | Ordinary Shares | 10985 | $0.00 | 19,136.0000 | 1,368,746,793 | 134.77% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | M | Common Stock | 1435 | $0.00 | 2,429.0000 | 103,700,000 | 144.37% | 0.00% |
| May 21, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | A | Restricted Stock Unit | 1659 | $0.00 | 1,659.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 21, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | A | Non-Qualified Stock Option | 3305 | $0.00 | 3,305.0000 | 103,700,000 | 9999.99% | 0.00% |
| Sept. 30, 2024 | BeOne Medicines Ltd. | $ONC | Sharp Shalini | Director | A | Ordinary Shares | 8151 | $0.00 | 8,151.0000 | 1,357,034,547 | 9999.99% | 0.00% |
| Sept. 30, 2024 | BeOne Medicines Ltd. | $ONC | Sharp Shalini | Director | A | Share Option (Right to Buy) | 17238 | $0.00 | 17,238.0000 | 1,357,034,547 | 9999.99% | 0.00% |
| June 7, 2024 | Organon & Co. | $OGN | Sharp Shalini | Director | A | Phantom Stock | 9639 | $20.75 | 36,783.9000 | 256,270,000 | 35.51% | 0.00% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | A | Restricted Stock Unit | 1435 | $0.00 | 1,435.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | A | Non-Qualified Stock Option | 2982 | $0.00 | 2,982.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | M | Common Stock | 2100 | $0.00 | 2,100.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | S | Common Stock | 1106 | $141.90 | 994.0000 | 101,000,000 | 52.67% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | M | Restricted Stock Unit | 2100 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| June 9, 2023 | Organon & Co. | $OGN | Sharp Shalini | Director | A | Phantom Stock | 10086 | $19.83 | 25,594.0000 | 255,169,000 | 65.04% | 0.00% |
| May 17, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | A | Non-Qualified Stock Option | 4290 | $0.00 | 4,290.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Sharp Shalini | Director | A | Restricted Stock Unit | 2100 | $0.00 | 2,100.0000 | 98,900,000 | 9999.99% | 0.00% |